Supplementary Materials from A Phase II Randomized Study of Neoadjuvant Letrozole Plus Alpelisib for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer (NEO-ORB)
Authors:
- Ingrid A. MayerIMIngrid A. Mayer
- Aleix PratAPAleix Prat
- Daniel EgleDEDaniel Egle
- Sibel BlauSBSibel Blau
- J. Alejandro Pérez FidalgoJFJ. Alejandro Pérez Fidalgo
- Michael GnantMGMichael Gnant
- Peter A. FaschingPFPeter A. Fasching
- Marco ColleoniMCMarco Colleoni
- Antonio C. WolffAWAntonio C. Wolff
- Eric P. WinerEWEric P. Winer
- Christian F. SingerCSChristian F. Singer
- Sara HurvitzSHSara Hurvitz
Open Access
- 31 March 2023
- other
- Published by American Association for Cancer Research (AACR)